Back to search

United Kingdom· GB-APID-4003311000001104

Homatropine 1% eye drops

A homatropine product containing homatropine, registered in United Kingdom by Martindale Pharmaceuticals Ltd. The same ATC class is registered in 5 of our 19 countries.

ATC S01FA05

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedHomatropine 1% eye dropsATCS01FA05REGISTER NO.GB-APID-4003311000001…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Homatropine is registered in 5 of 19 countries.

Countries holding a registration under ATC S01FA05 (homatropine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 3 of them publish a price we can compare per daily dose

Homatropine · ATC S01FA05

5 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Japan
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Homatropine
Manufacturer
Martindale Pharmaceuticals Ltd
Country
United Kingdom (GB)
ATC code
S01FA05
ATC class
Homatropine
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5014124374119

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

20 interactions on record for homatropine.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Homatropine · interactions on record

20 records

  • 3 severe
  • 17 moderate

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • DicycloverineA03AA07moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Homatropine in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All homatropine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/eea1243f-63ee-4816-a2ff-95bd6f41abcb
GET /v1/drugs/eea1243f-63ee-4816-a2ff-95bd6f41abcb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "4003311000001104",
  "desc": "Homatropine 1% eye drops (Martindale Pharmaceuticals Ltd)",
  "form": "Eye drops",
  "vpid": "42190611000001100",
  "source": "dmd",
  "vtm_id": "776197000",
  "strength": "10 mg",
  "substance": "Homatropine",
  "ingredient": "Homatropine hydrobromide",
  "supplier_code": "3146701000001109"
}

See everything about homatropine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.